Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Kairos Pharma, Ltd. (KAPA) had Return on Equity of -23.71% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-1.42M |
|
-- |
|
-- |
|
$1.46M |
|
$-1.46M |
|
$0.03M |
|
$-1.42M |
|
$-1.42M |
|
$-1.42M |
|
$-1.42M |
|
$-1.42M |
|
$-1.42M |
|
$-1.46M |
|
$-0.12M |
|
17.21M |
|
17.21M |
|
$-0.08 |
|
$-0.08 |
|
| Balance Sheet Financials | |
$4.84M |
|
-- |
|
$1.83M |
|
$6.67M |
|
$0.68M |
|
-- |
|
-- |
|
$0.68M |
|
$6.00M |
|
$5.86M |
|
$6.00M |
|
17.74M |
|
| Cash Flow Statement Financials | |
$-1.52M |
|
-- |
|
$3.28M |
|
$1.27M |
|
$3.03M |
|
$1.76M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.16 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.52M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-23.71% |
-24.29% |
|
-21.31% |
|
-23.71% |
|
$0.34 |
|
$-0.09 |
|
$-0.09 |
|